What if the drug did not have to adapt to the device? In this webinar, we explore how a more adaptable approach to autoinjector platforms can accommodate evolving drug profiles and patient needs, while giving pharmaceutical companies greater freedom to create a device suited to their portfolio and brand.
Traditional off-the-shelf autoinjector platforms provide a valuable starting point for device development, but their predefined design envelopes can limit how far a device can be adapted when drug, patient or portfolio requirements change. As pharmaceutical pipelines evolve, this creates an important question: how can companies retain the efficiencies of a platform while gaining greater freedom to configure the device around their specific needs?
In this webinar, we will explore a more adaptable approach to autoinjector platform development. Using the MGS A.i.r. Platform™ as an example, we will examine how a tested core technology can be configured around different drug characteristics, including viscosity, fill volume, pre-filled syringe requirements and injection time. We will also look at how patient and user considerations can influence activation profiles, audible feedback, device geometry and other aspects of the injection experience.
The session will connect these technical and human factors considerations with the development process itself. We will discuss how early feasibility assessment, modelling, prototyping and user testing can help teams investigate the fit between an asset portfolio and a device platform before committing to full development. The A.i.r. development approach starts from tested core technology and uses drug adaptation, user adaptation, 3D modelling and simulation to progress towards functional devices for verification.
Finally, we will consider what platform customization means beyond technical performance. Shape, colour, labels, embossing and other design elements can support brand representation, while material choices, part count and end-of-use considerations introduce another dimension to platform configuration.
The webinar is intended for professionals involved in combination products, drug delivery, device development and product strategy who want to understand how adaptable platform thinking can connect drug requirements, patient needs and efficient development.
By ticking this box, you consent to receiving communications from MGS Healthcare Manufacturing related to this topic and other products or services within their portfolio